Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Link

Showing results (191-200 of 328) with videos related to

Pageof 33
Sort By:
JCO Oncology Practice|May 20, 2022
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort AnalysisChristopher S Strouse, Melissa C Larson, Shawna L Ehlers, et al.
Blood|February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphomaYvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell LymphomaMatthew J Maurer, Fredrik Ellin, Line Srour, et al.
Hemasphere|July 11, 2022
A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)Gilles Salles, Stephen J Schuster, Luca Fischer, et al.
Blood|November 26, 2014
Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphomaMuhammad A Mir, Matthew J Maurer, Steven C Ziesmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2018
Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US CohortsClémentine Sarkozy, Matthew J Maurer, Brian K Link, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2019
Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysisAngelo Fama, Melissa C Larson, Brian K Link, et al.
Lancet (London, England)|November 22, 2001
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trialJ P Neoptolemos, J A Dunn, D D Stocken, et al.
Blood|November 5, 2010
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemiaTait D Shanafelt, Matthew T Drake, Matthew J Maurer, et al.
Blood|August 5, 2017
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 studyMichael Crump, Sattva S Neelapu, Umar Farooq, et al.
Pageof 33

Showing results (191-200 of 328) with videos related to

Sort By:
Pageof 33
JCO Oncology Practice|May 20, 2022
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort AnalysisChristopher S Strouse, Melissa C Larson, Shawna L Ehlers, et al.
Blood|February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphomaYvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell LymphomaMatthew J Maurer, Fredrik Ellin, Line Srour, et al.
Hemasphere|July 11, 2022
A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)Gilles Salles, Stephen J Schuster, Luca Fischer, et al.
Blood|November 26, 2014
Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphomaMuhammad A Mir, Matthew J Maurer, Steven C Ziesmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2018
Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US CohortsClémentine Sarkozy, Matthew J Maurer, Brian K Link, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2019
Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysisAngelo Fama, Melissa C Larson, Brian K Link, et al.
Lancet (London, England)|November 22, 2001
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trialJ P Neoptolemos, J A Dunn, D D Stocken, et al.
Blood|November 5, 2010
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemiaTait D Shanafelt, Matthew T Drake, Matthew J Maurer, et al.
Blood|August 5, 2017
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 studyMichael Crump, Sattva S Neelapu, Umar Farooq, et al.
Pageof 33